Jianmin Pharmaceutical Group Co (SHSE:600976) Accounts Payable & Accrued Expense : ¥921 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Accounts Payable & Accrued Expense?

Jianmin Pharmaceutical Group Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥1,005 Mil) to Dec. 2024 (¥1,000 Mil) and declined from Dec. 2024 (¥1,000 Mil) to Mar. 2025 (¥921 Mil).

Jianmin Pharmaceutical Group Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥842 Mil) to Dec. 2023 (¥1,055 Mil) but then declined from Dec. 2023 (¥1,055 Mil) to Dec. 2024 (¥1,000 Mil).

Jianmin Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

Jianmin Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

545.73

684.96

842.08

1,054.86

1,000.12

Jianmin Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,198.60	966.19	1,004.89	1,000.12	921.07

Jianmin Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jianmin Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052

Website

http://www.whjm.com

Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.

Executives

Du Ming De	Director
He Qin	Director
Gao Kai	senior management
Wang Jun	senior management
Huang Zhi Jun	senior management
Pei Xue Jun	senior management
Bu Zhong Jiang	Director
Cheng Chao Yang	senior management
Xu Sheng	senior management
Hu Zhen Bo	senior management
Liu Qin Qiang	Director
Xiong Fu Liang	senior management
Liu Peng	senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines